&#xa0;

[[[Written evidence submitted by the Department of Health (AMR0043)]]]

[[[&#xa0;]]]Introduction&#xa0;&#xa0;&#xa0;

[[[&#xa0;]]]How has antimicrobial resistance developed in the past decade? 

[[[&#xa0;]]]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;

[[[&#xa0;]]]What are the gaps in our knowledge about antimicrobial resistance? 

[[[&#xa0;]]]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;

[[[Multi Drug Resistant Bacteria]]]

[[[Metric]]]Klebsiella - carbapenem% non-susceptible to imipenem &amp;/or meropenemE. coli - cephalosporin% non-susceptible to cefotaxime &amp;/or&#xa0;ceftazidimeE. coli - fluoroquinolone% non-susceptible to ciprofloxacinPseudomonas - carbapenem% non-susceptible to imipenem &amp;/or meropenemN. gonorrhoeae - ceftriaxone% non-susceptibleKlebsiella - cephalosporin% non-susceptible to cefotaxime &amp;/or ceftazidimePseudomonas - cephalosporin% non-susceptible to ceftazidimeE. coli - gentamicin% non-susceptibleS. pneumoniae - penicillin% non-susceptible&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;

[[[&#xa0;]]]Is there sufficient research and investment into new antibiotics or other treatments and methods to ensure continued protection against infection?  If not, how could this be rectified?&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;

[[[&#xa0;]]]What measures (including behavioural change) have been most effective in controlling the spread of resistant pathogens, and could such measures be used to control other pathogens? 

[[[&#xa0;]]]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;Behaviour change and AMR &#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;

[[[&#xa0;]]]What global coordination and action is required to fight antimicrobial resistance and is the UK contributing enough towards cross-border initiatives?

[[[&#xa0;]]]&#xa0;Raising the international profile of AMR&#xa0;&#xa0;&#xa0;&#xa0;The pipeline of new antibiotics and novel treatments&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;What are the strengths and weaknesses of the Government’s 2013-2018 Strategy for tackling antimicrobial resistance? What changes might be made to further strengthen the Government’s action plan?&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;November 2013&#xa0;&#xa0; http://www.who.int/mediacentre/factsheets/fs194/en/http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4078448.pdf http://www.who.int/drugresistance/WHO_Global_Strategy_English.pdf https://www.gov.uk/government/publications/chief-medical-officer-annual-report-volume-2 Gram-negative bacteria are bacteria that retain crystal violet dye in the Gram staining protocol, and are associated with resistance against antibiotics. https://www.gov.uk/government/publications/uk-5-year-antimicrobial-resistance-strategy-2013-to-2018 http://www.hpa.org.uk/Publications/InfectiousDiseases/Tuberculosis/1308TBintheUK2013report/ Gonorrhoea is a sexually acquired infection caused by the bacterium Neisseria gonorrhoeae. Data drawn from the following sources:·&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; Past and current population estimates for England: http://nww.indicators.ic.nhs.uk/webview/; ·&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; ONS population projections from HSCIC population statistics database: https://login.hscic.gov.uk/Login.aspx?version=4&amp;referrer=http%3a%2f%2fmy.hscic.gov.uk%2f&amp;info=http%3a%2f%2fmy.hscic.gov.uk%3a80%2fSignIn.htm·&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; PHE Mandatory Surveillance Database of Healthcare Associated Infections.DH query on the period January 2011 to September 2013.&#xa0; ·&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; Residential Care:&#xa0;&#xa0;&#xa0; http://www.lse.ac.uk/LSEHealthAndSocialCare/pdf/Dilnot_report.pdf; &#xa0; http://www.nice.org.uk/media/842/61/HCAIQualityImprovementGuide.pdf http://www.nice.org.uk/nicemedia/live/13683/58591/58591.pdf http://apps.who.int/iris/bitstream/10665/77376/1/9789241504485_eng.pdf More information on ESPAUR is available at http://www.ncbi.nlm.nih.gov/pubmed/24027247 These were set out at annex C of the UK Five Year Antimicrobial Resistance Strategy (2013). 2012-2017 These figures do not include investment in wider underpinning research which is important for increasing knowledge of the basic biology of the organisms or hosts. However the EPSRC data does include investment in developing epidemiological models of infectious diseases, techniques to diagnose and monitor infectious disease and novel antimicrobial therapeutics/agents in response to drug resistance.&#xa0; See Pharmatimes, September 2013 UK Five Year Antimicrobial Resistance Strategy; page 16 -20 (2013). http://jac.oxfordjournals.org/content/66/suppl_2/ii41.full https://www.gov.uk/government/publications/the-health-and-social-care-act-2008-code-of-practice-on-the-prevention-and-control-of-infections-and-related-guidance. http://www.his.org.uk/files/3813/7088/0820/4_epic2_National_Evidence-Based_Guidelines_for_Preventing_Healthcare-Associated_Infections_in_NHS_Hospitals_in_England_2007.pdf&#xa0; https://www.gov.uk/government/publications/antimicrobial-stewardship-start-smart-then-focus Prevention and control of infection in care homes - an information resourcehttps://www.gov.uk/government/uploads/system/uploads/attachment_data/file/214929/Care-home-resource-18-February-2013.pdf&#xa0; Antimicrobial prescribing and stewardship competences.&#xa0;&#xa0; Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infections and Public Health England.&#xa0; (September 2013)https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/253094/ARHAIprescrcompetencies__2_.pdf&#xa0; http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1294740725984. http://www.ncbi.nlm.nih.gov/pubmed/21317398 Interventions to improve antibiotic prescribing practices for hospital inpatients (2013)Peter Davey, Erwin Brown, Esmita Charani, Lynda Fenelon, Ian M Gould, Alison Holmes, Craig R Ramsay, Philip J Wiffen,&#xa0; Mark Wilcox.http://www1.imperial.ac.uk/resources/0FFB1648-10D4-4CBD-9472-CA6247A9655D/daveypetalcochranedatabaseofsystematicreviews2013.pdf .&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; Ivers N, Jamtvedt G, Flottorp S, Young JM, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012, Issue 6. Art. No.: CD000259. DOI: 10.1002/14651858.CD000259.pub3.&#xa0;